Hans Georg Sahl
Cited by
Cited by
Antimicrobial and host-defense peptides as new anti-infective therapeutic strategies
REW Hancock, HG Sahl
Nature biotechnology 24 (12), 1551-1557, 2006
A new antibiotic kills pathogens without detectable resistance.
LK Ling LL, Schneider T, Peoples AJ, Spoering AL, Engels I, Conlon BP ...
Nature 517 (7535), 455-459., 2015
Ribosomally synthesized and post-translationally modified peptide natural products: overview and recommendations for a universal nomenclature
PG Arnison, MJ Bibb, G Bierbaum, AA Bowers, TS Bugni, G Bulaj, ...
Natural product reports 30 (1), 108-160, 2013
The co-evolution of host cationic antimicrobial peptides and microbial resistance
A Peschel, HG Sahl
Nature Reviews Microbiology 4 (7), 529-536, 2006
Insights into the mode of action of chitosan as an antibacterial compound
D Raafat, K Von Bargen, A Haas, HG Sahl
Applied and environmental microbiology 74 (12), 3764-3773, 2008
Use of the cell wall precursor lipid II by a pore-forming peptide antibiotic
E Breukink, I Wiedemann, C Kraaij, OP Kuipers, HG Sahl, B De Kruijff
Science 286 (5448), 2361-2364, 1999
Specific binding of nisin to the peptidoglycan precursor lipid II combines pore formation and inhibition of cell wall biosynthesis for potent antibiotic activity
I Wiedemann, E Breukink, C Van Kraaij, OP Kuipers, G Bierbaum, ...
Journal of Biological Chemistry 276 (3), 1772-1779, 2001
Chitosan and its antimicrobial potential–a critical literature survey
D Raafat, HG Sahl
Microbial biotechnology 2 (2), 186-201, 2009
Lantibiotics: mode of action, biosynthesis and bioengineering
G Bierbaum, HG Sahl
Current pharmaceutical biotechnology 10 (1), 2-18, 2009
Lantibiotics: biosynthesis and biological activities of uniquely modified peptides from gram-positive bacteria
HG Sahl, G Bierbaum
Annual Reviews in Microbiology 52 (1), 41-79, 1998
Plectasin, a fungal defensin, targets the bacterial cell wall precursor Lipid II
T Schneider, T Kruse, R Wimmer, I Wiedemann, V Sass, U Pag, A Jansen, ...
Science 328 (5982), 1168-1172, 2010
Dysregulation of bacterial proteolytic machinery by a new class of antibiotics
H Brötz-Oesterhelt, D Beyer, HP Kroll, R Endermann, C Ladel, ...
Nature medicine 11 (10), 1082-1087, 2005
Matrix-assisted laser desorption ionization-time of flight mass spectrometry for fast and reliable identification of clinical yeast isolates
G Marklein, M Josten, U Klanke, E Muller, R Horré, T Maier, T Wenzel, ...
Journal of clinical microbiology 47 (9), 2912-2917, 2009
Role of lipid‐bound peptidoglycan precursors in the formation of pores by nisin, epidermin and other lantibiotics
H Brötz, M Josten, I Wiedemann, U Schneider, F Götz, G Bierbaum, ...
Molecular microbiology 30 (2), 317-327, 1998
The lantibiotic mersacidin inhibits peptidoglycan synthesis by targeting lipid II
H Brötz, G Bierbaum, K Leopold, PE Reynolds, HG Sahl
Antimicrobial agents and chemotherapy 42 (1), 154-160, 1998
Mode of action of the peptide antibiotic nisin and influence on the membrane potential of whole cells and on cytoplasmic and artificial membrane vesicles
E Ruhr, HG Sahl
Antimicrobial agents and chemotherapy 27 (5), 841-845, 1985
Biosynthesis and biological activities of lantibiotics with unique post‐translational modifications
HG Sahl, RW Jack, G Bierbaum
European Journal of Biochemistry 230 (3), 827-853, 1995
New developments in RiPP discovery, enzymology and engineering
M Montalbán-López, TA Scott, S Ramesh, IR Rahman, AJ Van Heel, ...
Natural product reports 38 (1), 130-239, 2021
Mode of action of modified and unmodified bacteriocins from Gram-positive bacteria
Y Héchard, HG Sahl
Biochimie 84 (5-6), 545-557, 2002
Daptomycin inhibits cell envelope synthesis by interfering with fluid membrane microdomains
A Müller, M Wenzel, H Strahl, F Grein, TNV Saaki, B Kohl, T Siersma, ...
Proceedings of the National Academy of Sciences 113 (45), E7077-E7086, 2016
The system can't perform the operation now. Try again later.
Articles 1–20